secwatch.observer — SEC 8-K summary
======================================

Issuer:     TENAX THERAPEUTICS, INC. (TENX)
CIK:        0000034956
Form:       8-K
Filed at:   2026-09-09T12:00:12+00:00
Accession:  0001193125-26-385910
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenax presents LEVEL clinical trial results at Cantor conference; data not in filing text
--------------------------------------------------------------------------------

- Tenax Therapeutics (TENX) presented at 2026 Cantor Global Healthcare Conference on Sept 9, 2026.
- Presentation titled 'LEVEL Clinical Trial Results' was published on company website and attached as Exhibit 99.1.
- Filing text contains only the presentation title slide; actual trial results are not included in the 8-K text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/34956/000119312526385910/0001193125-26-385910-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/34956/000119312526385910/d43255d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-385910

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer